Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11:06 | Stock index futures muted as trade talks stay in focus | ||
10:54 | Meta's Zuckerberg hiring to form 'superintelligence' AI team - report | ||
10:42 | U.S. should treat Taiwan as a partner, not as an adversary, says AmCham | ||
10:42 | European indexes mixed as investors await U.S.-China updates, German defense stocks dip | ||
10:18 | Nokia, Leonardo team up on global private wireless networks for public safety | ||
10:06 | Molecular Partners to cut jobs, cash reach now anticipated to extend into 2028 | ||
09:54 | UnitedHealth weighs $1B deal for Banmedica in bid to exit Latin America - report | ||
09:54 | Culp enters multi-year agreement with its largest hareholder | ||
09:54 | Taiwan Semiconductor's May sales jump 39.6% as AI demand stays strong | ||
09:42 | ASE Technology's May revenue rises 8.1% Y/Y to $1.59B | ||
09:30 | Xometry drops 4%, prices $225M convertible senior notes | ||
09:24 | WEAVE LIVING and KKR expand partnership, acquire prime Tokyo residential portfolio | ||
09:18 | Skanska secures $240M contract for an engineering facility in Virginia | ||
09:12 | Virtu Financial announces strategic TradeOPS collaboration | ||
09:12 | Uniti Group prices $600M senior unsecured notes | ||
09:06 | Mitsubishi Electric's ME Innovation Fund invests in carbon credit monitoring startup Archeda | ||
09:06 | Morgan Stanley is raising over $5 billion debt for Elon Musk's xAI - report | ||
08:54 | Mtron secures $3M U.S. defense production contract | ||
08:30 | Ibotta authorizes additional $100 million for share repurchase | ||
08:30 | Huawei chips lag one generation behind U.S., but company pursuing workarounds, CEO says | ||
08:12 | UK's unemployment rate rises to 4.6% in April | ||
08:06 | Ispire Malaysia reaffirms full regulatory compliance and export-only manufacturing operations | ||
08:06 | AT&T reaffirms Q2 and FY25 guidance; plans $10B share buyback program | ||
08:00 | Nature's Sunshine announces 2.85M share secondary offering | ||
07:54 | Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments |